Loading...
Docoh

Tilray Brands (TLRY)

Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 17 countries spanning five continents.

Company profile

Ticker
TLRY
Exchange
Website
CEO
Brendan Kennedy
Employees
Incorporated
Location
Fiscal year end
Former names
Tilray, Inc.
SEC CIK
Subsidiaries
Natura Naturals Inc. • Tilray, Inc. • Manitoba Harvest USA LLC • Tilray Canada Ltd. • Dorada Ventures Ltd. • FHF Holdings Ltd. • High Park Farms Ltd. • Tilray Deutschland GmbH • Pardal Holdings, Lda. • Tilray Portugal Unipessoal, Lda. ...

TLRY stock data

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

28 Jul 22
1 Oct 22
31 May 23
Quarter (USD) May 22 Feb 22 Nov 21 Aug 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) May 22 May 21 Dec 20 Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 415.91M 415.91M 415.91M 415.91M 415.91M 415.91M
Cash burn (monthly) (no burn) 6.05M 155.81M 45M 6.84M 14.77M
Cash used (since last report) n/a 24.33M 626.93M 181.07M 27.53M 59.44M
Cash remaining n/a 391.58M -211.03M 234.84M 388.38M 356.47M
Runway (months of cash) n/a 64.8 -1.4 5.2 56.8 24.1

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
6 Sep 22 Kennedy Brendan Class 2 Common Stock Sell Dispose S No Yes 3.2229 350,000 1.13M 6,924,196
17 Aug 22 Carl A Merton RSU Sale back to company Dispose D No No 4.06 10,998 44.65K 268,181
17 Aug 22 Carl A Merton RSU Grant Acquire A No No 0 20,750 0 279,179
17 Aug 22 Carl A Merton RSUs Class 2 Common Stock Option exercise Dispose M No No 0 20,750 0 0
9 Aug 22 David G. Hopkinson Class 2 Common Stock Option exercise Dispose M No No 3.9 12,000 46.8K 3,314
5 Aug 22 Kennedy Brendan Class 2 Common Stock Sell Dispose S No Yes 3.9117 350,000 1.37M 7,274,196
3 Aug 22 Carl A Merton Class 2 Common Stock (RSUs) Payment of exercise Dispose F No No 3.88 12,238 47.48K 258,429
3 Aug 22 Carl A Merton Common Stock (Restricted (Deferred) Stock Units ("RSUs")) Option exercise Acquire M No No 0 23,089 0 270,667
3 Aug 22 Carl A Merton RSUs Class 2 Common Stock Option exercise Dispose M No No 0 23,089 0 0
13F holders Current Prev Q Change
Total holders 345 367 -6.0%
Opened positions 39 61 -36.1%
Closed positions 61 72 -15.3%
Increased positions 100 106 -5.7%
Reduced positions 69 82 -15.9%
13F shares Current Prev Q Change
Total value 274.99M 609.8M -54.9%
Total shares 71.38M 69.74M +2.3%
Total puts 14.33M 20.88M -31.3%
Total calls 14.13M 26.06M -45.8%
Total put/call ratio 1.0 0.8 +26.6%
Largest owners Shares Value Change
Etf Managers 8.35M $27.65M -13.1%
MS Morgan Stanley 8.29M $25.85M +219.8%
Susquehanna International 7.12M $22.2M +17.2%
CVI Investments 7.01M $57.93M 0.0%
Two Sigma Investments 2.32M $7.23M NEW
Vanguard 2.09M $6.51M +1.2%
Citadel Advisors 1.71M $5.34M +22.9%
BMO Bank of Montreal 1.54M $5.31M -6.9%
BLK Blackrock 1.43M $4.46M +2.4%
Sculptor Capital 1.38M $4.3M 0.0%
Largest transactions Shares Bought/sold Change
MS Morgan Stanley 8.29M +5.7M +219.8%
Two Sigma Investments 2.32M +2.32M NEW
NA National Bank of Canada 45.93K -1.93M -97.7%
GS Goldman Sachs 554.93K -1.53M -73.4%
D. E. Shaw & Co. 31.98K -1.48M -97.9%
Millennium Management 31.42K -1.36M -97.7%
BAC Bank Of America 823.5K -1.31M -61.4%
Etf Managers 8.35M -1.26M -13.1%
Susquehanna International 7.12M +1.05M +17.2%
Thrivent Financial For Lutherans 708.9K +708.9K NEW

Financial report summary

?
Risks
  • Regulations constrain our ability to market and distribute our products in Canada.
  • United States regulations relating to hemp-derived CBD products are new and rapidly evolving, and changes may not develop in the timeframe or manner most favorable to our business objectives.
  • We are exposed to risks relating to the laws of various countries as a result of our international operations.
  • Our strategic alliances and other third-party business relationships may not achieve the intended beneficial impact and expose us to risks.
  • We may not be able to successfully identify and execute future acquisitions, dispositions or other equity transactions or to successfully manage the impacts of such transactions on our operations.
  • We are subject to risks inherent in an agricultural business, including the risk of crop failure.
  • We depend on significant customers for a substantial portion of our revenue. If we fail to retain or expand our customer relationships or significant customers reduce their purchases, our revenue could decline significantly.
  • We may be unable to attract or retain key personnel, and we may be unable to attract, develop and retain additional employees required for our development and future success.
  • Significant interruptions in our access to certain supply chains for key inputs such as raw materials, supplies, electricity, water and other utilities may impair our operations.
  • Fluctuations in cannabinoid prices relative to contracted prices with third party suppliers could negatively impact our earnings.
  • We face risks associated with the transportation of our products to consumers in a safe and efficient manner.
  • Our products may be subject to recalls for a variety of reasons, which could require us to expend significant management and capital resources.
  • We may be subject to product liability claims or regulatory action. This risk is exacerbated by the fact that cannabis use may increase the risk of serious adverse side effects.
  • We, or the cannabis industry more generally, may receive unfavorable publicity or become subject to negative consumer or investor perception.
  • Failure to comply with safety, health and environmental regulations applicable to our operations and industry may expose us to liability and impact operations.
  • We may experience breaches of security at our facilities, which could result in product loss and liability.
  • We may be subject to risks related to our information technology systems, including service interruption, cyber-attacks and misappropriation of data, which could disrupt operations and may result in financial losses and reputational damage.
  • The cannabis industry continues to face significant funding challenges, and we may not be able to secure adequate or reliable sources of funding, which may impact our operations and potential expansion.
  • Our existing and future debt agreements may contain covenant restrictions that limit our ability to operate our business and pursue beneficial transactions.
  • Servicing our debt will require a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.
  • Management may not be able to successfully establish and maintain effective internal controls over financial reporting.
  • Because a significant portion of our sales are generated in Canada and other countries outside the United States, fluctuations in foreign currency exchange rates could harm our results of operations.
  • We may have exposure to greater than anticipated tax liabilities, which could harm our business.
  • The terms of our outstanding warrants may limit our ability to raise additional equity capital or pursue acquisitions, which may impact funding of our ongoing operations and cause significant dilution to existing stockholders.
  • We may not have the ability to raise the funds necessary to settle conversions of the Convertible Securities in cash or to repurchase the Convertible Securities upon a fundamental change.
  • The conditional conversion feature of the Convertible Securities, if triggered, may adversely affect our financial condition and operating results.
  • Certain provisions in the indentures governing the Convertible Securities may delay or prevent an otherwise beneficial takeover attempt of us.
  • Our stockholders may be subject to dilution resulting from future offerings of common stock by us.
  • Provisions in our corporate charter documents could make an acquisition of us more difficult and may prevent attempts by our stockholders to replace or remove our current board of directors.
Management Discussion
  • All these non-GAAP financial measures should be considered in addition to, and not in lieu of, the financial measures calculated and presented in accordance with accounting principles generally accepted in the United States of America, (“GAAP”). These measures, which may be different than similarly titled measures used by other companies, are presented to help investors’ overall understanding of our financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.  Please see “Reconciliation of Non-GAAP Financial Measures to GAAP Measures” below for a reconciliation of such non-GAAP Measures to the most directly comparable GAAP financial measures.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: abovementioned, accredited, adventure, Alpine, ambition, Andre, Andy, AOR, Apotheke, artisanal, aspect, Atlantic, ATM, attorney, bar, beloved, blocked, boast, Bob, Bouchard, bourbon, BRC, Breckenridge, Cain, chancellor, Charlie, Cheese, clean, coalition, combat, constriction, cornerstone, coupled, DDH, debating, deceleration, decriminalize, DeFrancecso, dignity, distilled, distillery, door, Duet, eclectic, enrolled, EPS, eroded, escalation, fit, Flash, flooding, floor, forbidden, Fort, French, geopolitical, gin, Green, heard, Henderson, HEXO, Hifyre, highlighting, Hong, HT, HTI, ID, inconsistency, inside, insider, invasion, Irish, Italian, Karl, Katherine, King, knowhow, Kong, Lauterbach, Lehenmatt, letter, LIBOR, LP, Luxembourg, MA, Macau, macroeconomic, Magazine, meantime, medium, MedMen, membership, milestone, military, Minister, ministry, music, NATO, NCI, Nelson, Neumunster, newest, official, Olaf, Omicron, onset, outlast, overachieved, owed, pad, panel, passport, peak, pilot, player, prejudice, principle, prosecution, Pucher, questioned, questioning, reader, reclaim, recoup, redundant, referendum, reinstated, remuneration, repudiating, resilient, restaurant, retaliatory, revisit, revive, Russia, Russian, SAC, saving, Schulz, scienter, seamlessly, Secretary, seizure, SH, shorter, shortly, signature, Singapore, SLC, society, soda, Sonsini, Spanish, steadfast, Suisse, Superhero, SWIFT, taproom, tasting, Telecommunication, therapy, therewith, traction, Treaty, UK, Ukraine, unspecified, unwilling, upcoming, uptick, vacant, variant, venue, vodka, waiver, whiskey, whisky, white, Wilson, winner
Removed: AB, abetting, accessed, accountable, administered, advanced, Africa, aiding, amounted, banning, beneficiary, blending, brewer, broker, capitalize, carryback, CBP, citizen, commonly, communicate, compounded, confectionary, connect, constraining, consummated, consummation, contemplated, contrary, crime, curtailment, customization, dealer, deductible, deep, defer, delayed, depth, devote, diminished, discerning, discretionary, disgorgement, disposed, Dorada, drying, ease, easier, electronic, eliminate, enforcing, engineering, entering, entirety, estate, exempted, expedient, extracting, facilitation, FHF, forma, forthcoming, fraudulent, gaining, genetic, Grail, gram, greenhouse, half, healthcare, herb, hospital, hulling, impacting, impediment, implicate, importation, impracticable, improved, InBev, informational, infringe, infringed, ingredient, instituted, insufficient, interfere, intrinsic, Japan, kg, kilogram, laundering, lawful, Lda, Leafly, lessee, lessor, licensee, licensor, lifetime, list, losing, lost, lowered, machinery, mainstream, manufactured, Marley, misconduct, multiplying, Natura, necessarily, oversupply, owner, Pardal, periodically, permanently, pest, PhD, Policing, Portuguese, practical, prepayment, pro, productivity, prohibiting, prompt, properly, proprietary, prospective, Pty, real, receipt, recruit, refund, remediation, renewal, replicate, residual, restraining, restriction, retired, retroactive, reversal, stemming, studying, substantively, successor, suffer, technical, technically, territorially, terrorist, therefrom, translate, trimming, true, understood, undertaken, Unipessoal, unmanaged, usage, variance, VIE, viewed, violate, violence, visitor, warehousing, widespread

Patents

Utility
Method for Qualitative And/or Quantitative Detection of Substances Contained In a Hemp Plant and Kit for Use Therein
24 Feb 22
The present invention relates to a kit comprising: a) an ampoule; b) a material comprising a hemp plant or parts thereof; and c) a color indicator capable of reacting by contacting the hemp plant and/or at least a part thereof to change the color of the color indicator, wherein the material and the color indicator are disposed in the ampoule; and a method for qualitatively and/or quantitatively detecting one or more substance(s) contained in the hemp plant using the kit.
Utility
Methods and apparatus for low-pressure radiant energy processing of cannabis
2 Nov 21
Methods and apparatuses for reducing the bioburden of cannabis using low-pressure radiant energy processing.
Utility
Oral Disintegrating Films for Cannabis Products
15 Jul 20
An oral disintegrating film including a cannabinoid or cannabinoid analogue, a first film forming polymer and a solubilizing agent are disclosed as well as methods of using same.
Utility
Novel Cannabinoid Compositions and Methods of Treating Pediatric Epilepsy
8 Jul 20
The present disclosure describes various novel compositions and methods, wherein said compositions and methods comprise CBD and THC in certain relative ratios.
Utility
Cannabinoid Formulations and Pharmaceutical Compositions
24 Jun 20
A formulation containing a cannabinoid or cannabinoid analogue in a delivery system, wherein the delivery system includes a mixture of at least one lipid and at least one surfactant, wherein the formulation self-emulsifies in an aqueous medium.